In contrast, a low anti-tumor effect of Pim and Gan was observed in PDCS that were generated from advanced pCRC with a low (<40% positive tumor cells) Hsp90α/β protein expression (patient IDs 5926 and 5941). The gene discussed is PIM1; the disease is neoplasm.